Elevate Medical Affairs Podcast Channel

Even before the COVID-19 pandemic, the structure and content of interactions between MSLs and KOLs/HCPs was shifting, with MSLs increasingly seen as trusted partners in scientific exchange and KOLs/HCPs increasingly open to technology-based communications. Of course, the pandemic has accelerated this change, shifting the mechanics of communication and collaboration and throwing into focus the definition of “value.” This podcast presents the expertise of leaders from pharmaceutical organizations Pfizer and Nektar, as well as Larvol, focusing on how MSLs bring value to HCPs and KOLs during the time of pandemic.Speakers: ·      Tim Hylan, VP, Internal Medicine Field Medical Director Group at Pfizer·      Sue Currie, VP, Head of Medical Affairs at Nektar Therapeutics·      Bruno Larvol, Founder and CEO at Larvol

The Series Podcast Objectives are:  Understand how the medical affairs strategic planning process can drive decision making throughout the year  Gain insight into the value medical affairs bring across an organization when an effective, collaborative, aligned medical strategy plan is developed  Obtain a working knowledge of how cross-functional teams within medical affairs can reference strategic plans to inform decision making and assess impact of efforts  Moderator: Monica DeAbadal, MD, MBA/HSA,VP, Medical Excellence, Ipsen Speaker: Peter Piliero, MD, VP & Head, Medical Affairs Americas, GSK Consumer HealthcareSpeaker: Eileen K Sawyer PhD, Vice-President, Global Medical Affairs, UniQureSpeaker: Len Valentino, MD, President and CEO, National Hemophilia FoundationSpeaker: Anna Walz, CEO, MedEvoke

Objectives: At the end of this series of podcasts, the participant should be able to:·         Discuss the functions and activities of key internal partners·         Identify potential areas for compliant collaboration by MSLs with key internal partners

In this third podcast episode in collaboration with Open Health, MAPS speaks with Jessica Ingram, Managing Director of Learning and Development at Open Health, and two of her team: Briony Frost, Learning Design and Development Specialist, and Jessamy Lowe, Senior Account Handler. Joining Jess, Jessie, and Briony is Seema Haider. Seema is the former Health Economics and Outcomes Research Cluster Lead for the Upjohn Business Unit at Pfizer. She also holds a Visiting Professorship at Hebei University, China, is a Faculty Lecturer at IFAPP-King’s College, London, and is an International Advisor for ISPOR India Chapter. In this podcast, they will be offering insights into metrics and how to measure the impact of internal training. . OPEN Health is a global, full-service medical communications agency offering Medical Affairs consultancy and content, publications, medical education and internal training. 

 In this second episode of the MAPS podcast series Elevate with medical communications and educational design experts from Open Health, we explore the development and delivery of internal training for Medical Affairs professionals: How do we ensure people do the training and can we also design for engagement and motivation? Does this look different in the digital environment?  Speakers include the following:Dirk Saerens, Scientific Knowledge Manager at Janssen EMEAJessica Ingram, Managing Director, Learning & Development, Medical Communications, OPEN HealthBriony Frost, Learning Design & Development Specialist, OPEN Health Ben Halford, Account Manager, OPEN Health

In partnership with Medical Communications and Educational Design experts from Open Health, this episode of the MAPS podcast series Elevate details how to position patients as priority in designing and refining internal training. How do we go about designing effective, outcome-focused internal training? Can effective internal training also be efficient? And is it expensive? What are the benefits for learners that you expect to result in benefits to patients? Join the following thought leaders for answers to these questions and more:Siobhan Mulhern-Haughey, Health Economics and Market Access Manager at Janssen EMEAJessica Ingram, Managing Director, Learning & Development, Medical Communications, OPEN HealthBriony Frost, Learning Design & Development Specialist, OPEN Health Rebecca Case, Account Manager, OPEN Health

Medical Affairs thought leaders discuss the Pre-21st Century Act uses of Real World Evidence (RWE) with Post-Marketing Surveillance to understand the impact of the 21st Century Act on RWE and Natural History Studies.

The Series Podcast Objectives are:  Understand how the medical affairs strategic planning process can drive decision making throughout the year  Gain insight into the value medical affairs bring across an organization when an effective, collaborative, aligned medical strategy plan is developed  Obtain a working knowledge of how cross-functional teams within medical affairs can reference strategic plans to inform decision making and assess impact of efforts  Monica DeAbadal, MD, MBA/HSA, Vice President, Medical Excellence at Ipsen and MAPS Medical Strategy & Launch Excellence co-lead, culled out highlights from the Medical Strategy Strategy Planning live session at the March 2020 Annual MAPS Conference.The session speakers who provided these critical intellectual components of Building the Medical Affairs Strategic Plan are: Peter Piliero, MD, Vice President & Head, Medical Affairs Americas at GSK Consumer Healthcare; Eileen K Sawyer, PhD, Vice-President, Global Medical Affairs, UniQure; Len Valentino, MD, President and CEO, National Hemophilia Foundation; and, Anna Walz, CEO of MedEvoke. 

Kathryn Gann, Independent Consultant, serves as the moderator for this session on Global Communications. In this podcast, Robin Winter-Sperry, MD, President & CEO, Scientific Resilience, interviews Aimee Christian, Ph.D., Global Head of Communications, Specialty Care, Sanofi-Genzyme.At the end of this series of podcasts, the audience should be able to:·         Discuss the functions and activities of key internal partners·         Identify potential areas for compliant collaboration by MSLs with key internal partners

In this first of two episodes, John Pracyk, MD, PhD, MBA speaks with Patrick Vega of Vizient Advisory Solutions about ways that device companies can capitalize on the shift from inpatient surgical settings to hospital outpatient departments, ASCs and outpatient sites of care. Presenters hypothesize that device companies that better understand the outpatient setting can more effectively adapt their products, services and support to meet customer needs.